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Aim: The aim of the study was to determine how values for white blood cell (WBC) counts, 
hemoglobin (Hb), hematocrit (Hct), mean corpuscular volume (mcv), and platelet counts vary 
with age and sex in healthy Malawians.  
Methods: We recruited 660 (316 male and 344 female) participants in 12 different age groups. 
An ethylenediaminetetraacetic acid-anticoagulated blood sample collected from each participant 
was analyzed using a hematological analyzer.
Results: WBC counts decreased with age with the lowest counts observed in the 20 to <60 
years old group. Median WBC counts for 20 to <60 year old females (5.9×109/L) were signifi-
cantly higher than those for men (4.7×109/L; p=0.015) of the same age. Hb and Hct increased 
between 5 and 10 years in males and 10 and 15 years in females to adult levels. Males aged 5 
to <10 years had significantly higher Hb (13.05 g/dL) and Hct (42.50%) compared to females 
of the same age (10.40 g/dL and 32.55%, respectively; p<0.0001 for both parameters). Plate-
let counts in males, which were highest between 3 and 5 years (376×109/L),  decreased to 
lowest counts among  5 to <10 year olds (238×109/L), while in females these decreased from 
402×109/L  in 6 to <10 years olds to 226×109/L in 10 to <15 year olds. mcv median values 
were high in neonates reaching a nadir at 13–18 months and then increased throughout life. 
Females aged 0 to <6 months had significantly higher mcv values (81.85 fL) than males of the 
same age (69.3 fL; p<0.0001).
Conclusion: This study provides hematological values according to age and sex that are suit-
able for reference use in studies among Malawian subjects. 
Keywords: hematological values, healthy Malawians, age, sex 
Introduction
Just as the immune system develops and matures with age,1 various hematological 
parameters have also been shown to change and develop with age2 although other fac-
tors such as genetics, sex, altitude, and life style may affect this process.3 Most of these 
factors vary depending on the population and geographical area studied,4,5 suggesting 
that reference values that have been validated for one country or age group cannot be 
assumed for application in populations from other countries.3
Reference ranges are important for monitoring pathophysiological changes after 
infection or disease or following the administration of drugs in therapeutic or clinical 
interventions and vaccine studies.6 Since diseases such as malaria and HIV/AIDS affect 
hematological parameters in different ways, analysis of blood samples for full blood 
counts (FBCs) is therefore now routinely performed to check for variations which 
could be due to these diseases.7 
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Studies in African countries have reported differences in 
normal values from those reported in other continents.8–11 Stud-
ies previously conducted to establish hematological reference 
values for a Malawian population limited their participants 
to children aged <1 year12,13 and young adults aged between 
19 and 30 years.14 We conducted this study to determine how 
white blood cells (WBC) counts, hemoglobin (Hb), hematocrit 
(Hct), mean corpuscular volume (mcv), and platelet counts 
vary with age and sex in Malawians from birth to adulthood. 
Materials and methods
Study area and recruitment of study 
participants
Some findings concerning the study site and the population 
investigated in this paper have been published before.5,15 
The study was conducted at the Ndirande Health Centre, 
Ndirande township, Blantyre, Malawi, between October and 
December 2005 and September and November 2006. Study 
participants were healthy volunteers from the township, 
were not HIV infected, had no known active disease, were 
not malnourished, not on treatment for any known infectious 
or noncommunicable disease, and were made aware of the 
study by health care assistants at immunization clinics and by 
local leaders in the community. Infants were recruited when 
they reported for routine vaccination, whereas adults were 
recruited from the community. Each study participant was 
assessed clinically by a trained research nurse and a clini-
cal officer, both with >5 years experience in assessing and 
recruiting study participants into clinical research projects.
The clinical assessment process included a review of 
each participant’s health passport, a booklet issued to every 
Malawian citizen from birth having medical records of all 
diagnoses and treatment given to that individual, and a 
clinical examination. With the aid of a brief questionnaire, 
participants were asked whether they were on any medication 
and whether they had a history of any illness.  Participants 
were assessed for febrile illness, infections such as malaria, 
severe malnutrition, and clinical AIDS. Severe malnutrition 
was defined as weight-for-height <70% in children or body 
mass index <16% in adults. Only those participants found 
to be afebrile (axillary temperature ≤38°C, not severely 
malnourished, not on any treatment, HIV uninfected, not 
infected with Plasmodium falciparum parasites, and with-
out any active or past history of recurrent or chronic infec-
tions) were defined as healthy and recruited into the study. 
Approximately 50 subjects were recruited into each of the 
following 12 age groups: neonates (cord blood sample), 0 
to <6, 6 to <12, 12 to <18, and 18 to <24 months, 2 to <3, 
3 to <5, 5 to <10, 10 to <15, 15 to <20, 20 to <60, and ≥60 
years. After informed consent, baseline demographic data, 
height, and weight were recorded, and a 5-mL blood sample 
was obtained with 1 mL collected in an ethylenediaminetet-
raacetic acid (EDTA)-anticoagulated tube. Informed consent 
was obtained from each participant or a parent or a guardian 
of every child. Exclusion criteria were presence of active 
disease and/or fever (>38°C axilla), receiving medication at 
the time of recruitment, and severe malnutrition (Figure 1). 
Blood samples were tested for HIV seropositivity and malaria 
parasitemia and the results of those participants found to be 
either HIV infected or parasitemic with P. falciparum were 
not included in the final data analysis. A follow-up appoint-
ment was offered 1 week later to give results to interested 
study participants. HIV-infected adults and children were 
referred to the antiretroviral therapy clinic. 
Investigations
HIV testing was performed using two rapid test kits; Deter-
mine (Abbott Laboratories, Abbott Park, IL, USA) and 
Unigold (Trinity Biotech, Dublin, Ireland). Thick and thin 
blood smears were prepared by standard methodology. WBC, 
Hb, Hct, mcv, and platelet counts were determined using an 
HMX Hematological Analyzer (Beckman Coulter, Brea, CA, 
USA) using the sample collected in the EDTA tube. 
Ethical approval
Ethical approval for this study was obtained from College 
of Medicine Research and Ethics Committee in Blantyre, 
Malawi.
Figure 1 A schematic presentation depicting the number of total potential study 
participants screened, how many were excluded from the study due to various 
reasons, and how many female and male participants had their data used in the final 
statistical analysis.
Total number of healthy
study participants who
qualified
(n=660) 
Total number of potential
participants screened
(n=723)
Female
(n=344)
Total number excluded
from the study due to
infections
(n=63)
Male
(n=316)
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age groups. Statistical tests were performed using GraphPad 
Prism version 6.01 for Windows (GraphPad Inc, La Jolla, 
CA, USA). The results in Table 2 are presented as median 
values (minimum and maximum range) of WBC, Hb, Hct, 
mcv, and platelet counts.
(Continued)
Table 1 Age distribution, sex, number and age (range) in months or years of the study participants whose data were used and reported 
on in the study
Age range Number of Study Participants and the medians and range of their ages  
Female Male Combined
Neonates (cord blood) 37 
–
24
–
61
–
0 to <6 months 44
3 (1–6) months
24
2 (1–6) months
68
3 (1–6) months
6 to <12 months 31
11 (7–12) months
35
10 (7–12) months
66
10.5 (7–12) months
12 to <18 months 15
15 (13–18) months
27
15 (13–18) months
42
15 (13–18) months
18 to <24 months 16
21.5 (19–23) months
33
22 (19–24) months
49
22 (19–24) months
2 to <3 years 20
2.4 (2.1–3.0) years
28
2.5 (2.1–3.0) years
48
2.4 (2.1–3.0) years
3 to <5 years 22
4.0 (3.1–5.0) years
29
4.4 (3.2–5.0) years
51
4.2 (3.1–5.0) years
5 to <10 years 30
7.1 (5.1–10.0) years
26
6.8 (5.3–10.0) years
56
7.0 (5.1–10.0) years
10 to <15 years 36
12.2 (10.1–14.9) years
17
11.2 (10.1–14.9) years
53
11.8 (10.1–14.9) years
15 to <20 years 29
18.0 (15.4–19.8) years
29
16.8 (15.4–20.0) years
58
17.2 (15.4–20.0)
20 to <60 years 33
23.9 (20.3–57.4)
20
22.0 (20.7–37.1) years
53
23.8 (20.3–57.4)
>60 years 31
65.0 (60.0–81.0) years
24
70.5 (60.0–92.0)
55
66.0 (60.0–92.0) years
Total Numbers 344 316 660
Statistical analysis
For statistical analysis, subjects were divided into 12 age 
groups as indicated in Table 1. Mann–Whitney test was used 
to determine the statistical significance of the observed dif-
ferences between male and female participants of different 
Table 2 Medians (minimum and maximum range) for WBC counts, Hb concentration, Hct percentage, mcv, and platelet counts for the study participants 
of different age and sex
Age group WBC
(109/L)
p–value
(M vs F)
Hb (g/dL) p–value
(M vs F)
Hct (%) p–value
(M vs F)
MCV
(fL)
p–value
(M vs F)
Platelet  
Count (109/L)
p–value
(M vs F)
Neonates 11.6 
(3.9–25.8)
11.30 
(7.60–14.30)
33.80 
(22.0–44.4)
86.91
(63.9–111.5)
383 
(106 –842)
Female 11.8 
(3.9–25.8) 0.350
11.20 
(8.80–12.90) 0.337
33.70 
(28.10–38.40) 0.177
88.3  
(63.9–100.2) 0.250
385 
(108–842) 0.813
Male 11.5 
(7.0–25.21)
11.70 
(7.60–14.30)
34.80 
(22.0–44.4)
84.1
(64.2–111.5)
355 
(106–612)
1–6 months 9.4 
(2.7–17.4)
11.45 
(7.40–13.40)
34.70 
(24.50–40.80)
77.05 
(53.6–98.3)
346 
(102–684)
Female 9.5 
(2.7–17.4) 0.232
11.55 
(7.40–13.40) 0.127
35.10 
(24.5–40.80) 0.193
81.85 
(66.3–98.3) <0.001
340 
(102–607) 0.419
Male 9.0 
(6.2–17.4)
10.65 
(8.10–13.30)
33.05 
(26.0–39.60)
69.3 
(53.6–78.8)
365 
(105–684)
7–12 months 10.65 
(3.1–25.1)
11.40 
(8.40–13.90)
34.70 
(26.40–40.80)
67.45 
(47.6–84.1)
312 
(106–518)
Female 10.4 
(6.7–19.6) 0.2336
11.20 
(8.40–13.30) 0.286
34.10 
(26.4–40.80) 0.464
66.6 
(49.2–83.0) 0.145
323 
(106–479) 0.822
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Table 2 (Continued)
Age Group WBC
(109/L)
p-value
(M vs F)
Hb (g/dL) p-value
(M vs F)
Hct (%) p-value
(M vs F)
MCV
(fL)
p-value
(M vs F)
Platelet 
Count (109/L)
p-value
(M vs F)
Male 11.2 
(3.1–25.1)
11.50 
(9.30–13.90)
34.70 
(27.8–40.70)
67.8
(47.6–84.1)
298 
(125–518)
13–18 months 10.45 
(5.5–25.10)
12.15 
(9.70–13.70)
36.20 
(26.30–40.70)
65.0 
(52.7–78.2)
307 
(101–564)
Female 10.1 
(7.4–15.7) 0.258
12.20 
(9.70–13.70) 0.121
36.3 
(26.3–40.70) 0.265
65.3 
(57.6–76.1) 0.177
306 
(153–517) 0.990
Male 11.2 
(5.5–25.1)
11.80 
(10.0–13.10)
36.0 
(29.7–39.8)
63.6 
(52.7–78.2)
308 
(101–564)
19–24 months 9.2 
(5.2–21.0)
11.40 
(7.00–14.50)
34.60 
(22.70–44.10)
72.7 
(54.8–88.7)
357 
(104–623)
Female 8.75 
(5.2–13.9) 0.234
10.55 
(8.10–14.50) 0.281
32.45 
(27.4–44.1) 0.348
70.85 
(56.3–86.8) 0.118
368 
(104–623) 0.898
Male 9.6 
(5.4–21.0)
11.50 
(7.0–13.60)
35.0 
(22.7–40.90)
72.8
 (54.8–88.7)
337 
(131–623)
>2–3 years 8.25 
(4.3–16.5)
10.25 
(7.40–13.40)
31.65 
(21.50–39.10)
76.4 
(54.5–92.0)
378 
(105–988)
Female 7.95 
(6.6–12.5) 0.145
10.25 
(7.80–13.00) 0.616
31.90 
(22.7–38.60) 0.484
76.4
 (54.5–85.3) 0.283
437 
(105–988) 0.158
Male 8.8 
(4.3–16.5)
10.20 
(7.40–13.40)
31.25 
(21.50–39.10)
76.45
(62.0–92.0)
361 
(112–755)
>3–5 years 7.9 
(4.6–12.9)
10.00 
(6.60–12.90)
31.10 
(23.60–38.80)
77.9 
(62.4–90.7)
447 
(100–915)
Female 8.05 
(4.7–11.7) 0.400
10.05 
(4.60–12.60) 0.581
31.2 
(15.40–38.80) 0.655
77.35 
(62.4–89.4) 0.222
478 
(100–915) 0.424
Male 7.6 
(4.6–12.9)
10.00 
(6.70–12.90)
31.10 
(236–38.20)
77.9 
(63.5–90.7)
376 
(110–755)
>5–10 years 6.45 
(3.3–14.7)
11.70 
(7.50–15.90)
36.40 
(21.90–50.40)
80.3 
(67.3–98.1)
288 
(103–719)
Female 6.6 
(4.1–14.1) 0.192
10.40 
(7.50–15.90) <0.0001
32.55 
(13.0–48.9) <0.0001
78.9 
(67.3–98.1) 0.249
402
(103–719) 0.0001
Male 6.3
 (3.3–14.7)
13.05 
(10.0–15.60)
42.50 
(32.5–50.4)
81.0 
(68.1–88.6)
238 
(104–388)
>10–15 years 5.7 
(3.3–9.7)
13.60 
(7.30–17.60)
41.90 
(22.60–55.10)
81.4 
(64.6–91.5)
249 
(108–428)
Female 5.7 
(3.5–9.7) 0.401
13.15
(7.30–17.60) 0.153
41.50 
(22.6–55.10) 0.581
82.25 
(64.6–91.5) 0.263
226 
(108–413) 0.185
Male 5.6
 (3.3–9.2)
14.10 
(12.10–15.70)
42.70 
(35.4–47.4)
80.4 
(66.5–86.5)
263 
(156–428)
>15–20 years 5.1 
(3.0–13.8)
14.40 
(8.00–17.60)
43.80 
(26.50–54.80)
85.5 
(65.5–96.0)
249 
(102–452)
Female 5.85 
(3.6–13.8) 0.015
14.70 
(11.80–16.90) 0.066
44.8 
(34.7–51.9) 0.086
86.25 
(65.5–96) 0.328
238 
(137–452) 0.523
Male 4.7 
(3.0–8.9)
14.10 
(8.0–17.60)
42.2 
(26.5–54.8)
84.7 
(72.3–93.4)
262 
(102–400)
>20–60 years 5.4 
(3.4–12.6)
12.80 
(7.40–16.40)
39.40 
(25.60–52.70)
87.1 
(54.0–102)
214 
(100–402)
Female 5.1 
(3.6–12.6) 0.464
12.60 
(7.40–16.20) 0.205
38.0 
(25.6–49.2) 0.145
84.6 
(57.2–98.7) 0.105
205 
(110–379) 0.160
Male 5.5 
(3.4–8.9)
13.0 
(9.50–16.40)
39.7 
(29.3–52.7)
89.6 
(54.0–102)
238 
(100–402)
>60 years 5.6 
(3.3–12.5)
13.50 
(8.30–18.00)
40.00 
(26.70–59.30)
89.3 
(58.9–111.0)
234 
(100–585)
Female 5.8 
(3.3–12.5) 0.215
13.50 
(8.30–17.90) 0.440
40.0 
(26.7–56.51) 0.641
89.3 
(72.9–111.0) 0.386
229 
(100–443) 0.235
Male 5.5 
(4.1–7.5)
13.45 
(9.70–18.0)
39.9 
(30.1–59.30)
89.45 
(58.9–103.3)
253 
(102–585)
Note: Bolded data represents the p-values that were equal to or less than 0.05 indicating a significant difference of the medians of the specific parameter between male and 
female participants of the specified age range.
Abbreviations: WBC, white blood cell; Hb, hemoglobin; Hct, hematocrit; mcv, mean corpuscular volume; M, male; F, female.
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Results 
Participants
In total, we screened 723 healthy Malawians of different ages. 
Sixty-three were eliminated from the study either because 
they were HIV infected, severely malnourished, had malaria 
or were asymptomatically infected with P.  falciparum, or were 
febrile, or found have any other infectious disease (Figure 1). 
The remaining 660 (316 males and 344 females) were divided 
into 12 different age groups for statistical analysis (Table 1). 
The median age and range values for each age group are 
 provided in Table 1. For study participants aged >60 years, 
the overall median age for both men and women was 66 years, 
the median age for female participants was 66 with a range 
of 60–81 years, and the median age for men was 70.5 years 
with a range of 61–92 years. Leukocyte and lymphocyte subset 
data of these study participants have been reported before.5,15 
Variation in hematological indices  
with age
Median WBC counts were high in neonates (11.6×109 
cells/L) through to 18 months of age (Table 2; Figure 2A). 
These then decreased in children aged between 19 and 24 
months and further decreased with age, plateauing among 
children aged 10–15 years at adult levels. Females aged 
15 to <20 years had significantly (p=0.015) higher WBC 
counts (5.9×109 cells/L) compared with  male participants 
Figure 2 Median (10th and 90th percentiles) of (A) WBC counts (109/L), (B) Hb levels (g/dL), (C) Hct levels (%), (D) mcv (fL), and (E) platelet counts (109/L) for female 
(red) and male (black) study participants of different age groups. 
Abbreviations: F, female; M, male; WBC, white blood cells; Hb, hemoglobin; Hct, hematocrit; mcv, mean corpuscular volume.
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(4.7×109 cells/L) of the same age (Table 2), an observation 
that has been noted before16 and attributed to hormonal 
changes in women.17 
Median Hb concentrations were low in neonates and 
young children (Figure 2B). These increased among males 
at 5–10 years and then among females at 15–20 years to 
reach the highest levels (median 14.40 g/dL) at 15–20 years 
(Table 2). Median Hct followed a near identical trend to Hb 
(Figure 2C). Male participants in the 5–10 years age group 
had significantly (p<0.0001 for both parameters) higher Hb 
(13.1 g/dL) and Hct (42.5%) compared with females of the 
same age (10.4 g/dL and 32.6%, respectively).
Median mcv peaked in neonates (87 fL), decreasing 
gradually with age to a nadir of 67.8 fL among children 
aged 13–18 months (Figure 2D). This was followed by a 
gradual increase reaching a peak of 89 fL in adults >60 years. 
Female babies in the 1–6 months age group had significantly 
(p<0.0001) higher mcv values (81.85 fL) compared with 
male babies in the same age group (69.3 fL) (Table 2). 
Median platelet counts peaked in the 3 to <5 years group 
for both girls (478×109/L) and boys (376×109/L) (Table 2; 
Figure 2E). This was a followed by a gradual decrease with 
the lowest counts (205×109/L for females and 238×109/L for 
males) observed in the 20 to <60 years aged group (Table 2). 
Females aged 6–10 years had significantly (p=0.0001) higher 
platelet counts compared with males (238×109/L) of the same 
age group (Table 2).
Discussion
We have reported values for WBC count, Hb, Hct, mcv, and 
platelet count for healthy Malawians residing in a township 
in Blantyre from birth to adults in their nineties. Male and 
female adults have lower values for WBC, Hb, Hct, mcv, 
and platelet counts compared to published standard values 
for Caucasian populations.18 In one age group in the current 
study (5–10 years), females had lower Hb and Hct values 
than males. Previous reports from Malawi only provided 
ranges for healthy children aged between 0 and 6 months,12 
in neonates,13 and in adults aged between 19 and 30 years.14 
The values from the present study fell within the ranges 
established for the previous study but provided more finesse 
and detail with respect to age and sex. In both studies, healthy 
study participants had hematological values outside reference 
ranges for Caucasian populations. In the absence of ranges 
established among Malawian subjects, such results could be 
misinterpreted as indicating an underlying medical problem. 
Similar to studies conducted among western popula-
tions,19,20 and other African populations,3,8 Hb and Hct levels 
in Malawian children were comparable regardless of sex from 
birth to 10 years. The age groups between 5 and 10 years for 
boys and 10 and 15 years for girls mark a transition from 
childhood to adulthood values, with Hct and Hb higher in 
the older age groups. Few publications have reported Hb 
variation with age to adulthood. One study, in an Indian 
population from the age of 12–90 years,21 and another one 
among British, American, and Canadian Caucasian subjects 
from birth to adulthood22 observed that male participants had 
higher Hb values compared with female participants from 
12 years onward. Overall, the Hb results obtained in our 
study are lower compared with those in the western adult 
population,22 but higher than those of the Indian study,21 and 
this might be attributed to a lower than normal dietary iron 
intake that could impair hematopoiesis.7 The finding could 
also be due to chronic erythrocyte loss due to intermittent 
malaria or hookworm infestation, both of which are common 
in the region.6
The difference observed in the age groups in which 
platelet counts drastically decreased,  between 3 and 5 years 
in males and 10 and 15 years in females, could be due to 
estrogen in females which has been associated with changes 
in platelet function.23 The lower platelet counts observed in 
the Malawian population compared to the standard reference 
ranges12 might be the result of environmental or genetic 
factors or both.17 However, the observation that even among 
African populations2–6 these counts vary substantially sug-
gests that environmental factors are important. Other studies 
have reported that adult females have higher2,7–9,17 or similar5,23 
platelet counts compared with adult males.
When compared to standard reference ranges,18 which are 
set for Caucasians aged between 20 and 60 years, Malawians 
had lower values for Hb, Hct, and platelet counts. When 
compared to values for other African subjects, Malawian 
male participants had lower Hb and Hct values than those 
in male participants from Uganda,8 Central African Repub-
lic,3 Botswana,6 Tanzania,9 and Kenya,10 consistent with the 
importance for environmental factors in determining such 
intercountry differences.
When the normal reference limits of the Beckman Coulter 
hematological analyzer, which were obtained after analyzing 
blood samples from healthy Malawian controls,14 were taken 
into consideration (2.8–7.2×109/L for WBC counts, 13.6–16.7 
g/dL for Hb, 39.0%–50.0% for Hct, 82.0–98.0 fL for mcv, 
and 115–290×109/L for platelets), results for all parameters 
analyzed in all age groups were within those set limits.
The results of this study complement findings from a pre-
vious Malawian study14 which found age and sex variations 
Journal of Blood Medicine 2017:8 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
129
Hematological range
of hematological values in participants aged between 19 and 
35 years.  Considering various studies that have reported a 
variation of hematological parameters based on ethnicity, age, 
and sex, the values reported in this study provide additional 
information on how such values vary with age and with sex 
in Malawi.
Limitations
Our study had a number of limitations including variations 
in the numbers of male and female participants in the differ-
ent age groups and lack of detailed information concerning 
past medical history, including recent infections. Collection 
of specimens was not performed at a constant time of the 
day and social details such as smoking were not recorded. 
Furthermore, all study participants were recruited from 
one location in Blantyre, Ndirande township, which is a 
peri-urban setting. Also, although we had planned to recruit 
equal numbers of participants for each group, we ended up 
with variable samples sizes for the different age groups and 
particularly for males and females in each group, partly 
through the exclusion of some participants based on the 
screening results included in Figure 1. Lastly, although a 
previous Malawian study14 had suggested the need for col-
lecting data on key behavioral, dietary, and environmental 
factors that might affect hematological variables, our study 
only excluded severely malnourished subjects.
Ndirande is a large township with >109,164 inhabit-
ants24 of different Malawian ethnic backgrounds including 
Chewa, Nyanja, and Ngoni from the central region, Yao, 
Mang’anja, and Sena from the southern region, and Tum-
buka and Nkhonde from the northern region, who have over 
the years migrated to the city.25 With such a diversity in the 
ethnic background of the study population, it is not easy to 
ascertain that the variations observed in hematological values 
from other studies are purely due to age or sex alone. Any 
future study aiming to establish reference hematological 
ranges representative of the ethnic tribes in Malawi will need 
to recruit participants of known ethnicity. If values from the 
same participants are collected at least at two time points, 
during the dry season and the wet season, the average of the 
two values would help eliminate seasonality as a potential 
confounder.
Conclusion
In conclusion, we have shown, as others have, that hema-
tological parameters vary with age and with sex. When 
compared with results of other studies, there are regional 
and ethnic differences in reference values of hematological 
 indices between African and Caucasian populations as we 
have previously described for leukocyte and lymphocyte 
subsets.5 Even among African populations, these values vary 
supporting the concept that each country should establish its 
own set of normal hematological reference ranges. These 
should be performed in carefully characterized healthy par-
ticipants representative of all ages and both sexes, and should 
ideally be representative of all ethnic groups in that country.
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